These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2464650

  • 1. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
    Bittard H.
    J Urol (Paris); 1988; 94(7):345-7. PubMed ID: 2464650
    [Abstract] [Full Text] [Related]

  • 2. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder.
    Lynch DF.
    Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118
    [Abstract] [Full Text] [Related]

  • 3. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F, Chrétien Y, Vallantin X, Collet C, Lachand AT, Dufour B.
    Ann Urol (Paris); 1988 Aug; 22(3):216-9. PubMed ID: 3401004
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 5. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F.
    Prog Clin Biol Res; 1988 Oct; 260():599-602. PubMed ID: 3362909
    [No Abstract] [Full Text] [Related]

  • 6. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
    Logothetis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE.
    Cancer Treat Rep; 1985 Jan; 69(1):33-8. PubMed ID: 2981619
    [Abstract] [Full Text] [Related]

  • 7. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O, Kakehi Y, Arai Y, Tomoyoshi T, Okada Y, Matsuda T, Mikami O, Fukuyama T, Hida S, Okabe T.
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [Abstract] [Full Text] [Related]

  • 8. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
    Sánchez Romero JA, Ramírez Ruiz F, Romero Fernández L, Pastor Gaitán P, Murillo Capitán E.
    Actas Urol Esp; 1989 Nov; 13(4):240-2. PubMed ID: 2678934
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer.
    Hrushesky WJ, Roemeling RV, Wood PA, Langevin TR, Lange P, Fraley E.
    Cancer Treat Rep; 1987 Oct; 71(10):915-9. PubMed ID: 3652055
    [Abstract] [Full Text] [Related]

  • 12. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA, de la Peña JJ, Hidalgo L, Cisneros J, Jiménez de León J, Machuca J.
    Arch Esp Urol; 1986 Oct; 39(1):33-46. PubMed ID: 3707210
    [No Abstract] [Full Text] [Related]

  • 13. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, van Boven H, Meinhardt W, Horenblas S.
    Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
    Logothetis CJ, Johnson DE, Chong C, Dexeus FH, Sella A, Ogden S, Smith T, Swanson DA, Babaian RJ, Wishnow KI.
    J Clin Oncol; 1988 Oct; 6(10):1590-6. PubMed ID: 3171626
    [Abstract] [Full Text] [Related]

  • 17. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y, Ogawa T, Yoshida T, Yamamoto S, Hirano A, Watanabe T, Shinka T, Ohkawa T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pre surgery chemotherapy in bladder cancer.
    Francini M, Veronesi A, Dal Bo V, Carbone A, Monfardini S.
    Prog Clin Biol Res; 1988 Aug; 260():585-9. PubMed ID: 3362908
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.